The Nuclear Receptor REV-Erbα Modulates Th17 Cell-Mediated Autoimmune Disease

Total Page:16

File Type:pdf, Size:1020Kb

The Nuclear Receptor REV-Erbα Modulates Th17 Cell-Mediated Autoimmune Disease The nuclear receptor REV-ERBα modulates Th17 cell-mediated autoimmune disease Christina Changa,b, Chin-San Looa,b, Xuan Zhaoc, Laura A. Soltd, Yuqiong Lianga, Sagar P. Bapata,c,e, Han Choc, Theodore M. Kameneckad, Mathias Leblanca, Annette R. Atkinsc, Ruth T. Yuc, Michael Downesc, Thomas P. Burrisf, Ronald M. Evansc,g,1, and Ye Zhenga,1 aNOMIS Center for Immunobiology and Microbial Pathogenesis, The Salk Institute for Biological Studies, La Jolla, CA 92037; bDivision of Biological Sciences, University of California San Diego, La Jolla, CA 92093; cGene Expression Laboratory, The Salk Institute for Biological Studies, La Jolla, CA 92037; dDepartment of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458; eMedical Scientist Training Program, University of California San Diego, La Jolla, CA 92093; fCenter for Clinical Pharmacology, Washington University School of Medicine and St. Louis College of Pharmacy, St. Louis, MO 63104; and gHoward Hughes Medical Institute, The Salk Institute for Biological Studies, La Jolla, CA 92037 Contributed by Ronald M. Evans, July 29, 2019 (sent for review May 9, 2019; reviewed by Ming O. Li and David D. Moore) T helper 17 (Th17) cells produce interleukin-17 (IL-17) cytokines In this study, we show that REV-ERBα is also a key feedback and drive inflammatory responses in autoimmune diseases such as regulator of RORγt in Th17 cells. REV-ERBα is specifically up- multiple sclerosis. The differentiation of Th17 cells is dependent on regulated during Th17 differentiation and plays a dual role in the retinoic acid receptor-related orphan nuclear receptor RORγt. Th17 cells. When expressed at a low level, REV-ERBα promotes Here, we identify REV-ERBα (encoded by Nr1d1), a member of the RORγt expression via the suppression of negative regulator nuclear hormone receptor family, as a transcriptional repressor NFIL3 as reported previously (15, 16). At high expression level, that antagonizes RORγt function in Th17 cells. REV-ERBα binds to REV-ERBα directly competes with RORγt binding to the loci of ROR response elements (RORE) in Th17 cells and inhibits the Th17 signature genes and suppresses Th17 effector function. Ele- expression of RORγt-dependent genes including Il17a and Il17f. vated REV-ERBα activity also ameliorates Th17-driven autoim- Furthermore, elevated REV-ERBα expression or treatment with a mune disease experimental autoimmune encephalomyelitis (EAE). synthetic REV-ERB agonist significantly delays the onset and impedes Our results suggest that modulating REV-ERBα activity could the progression of experimental autoimmune encephalomyelitis provide a way to manipulate Th17 cells in autoimmune diseases. (EAE). These results suggest that modulating REV-ERBα activity may be used to manipulate Th17 cells in autoimmune diseases. Results REV-ERBα Is Highly Expressed during Th17 Cell Differentiation. In an transcriptional repressor | autoimmunity | nuclear receptors effort to identify novel players in the nuclear hormone receptor superfamily that are involved in T cell function, we conducted ex- helper 17 (Th17) cells are the drivers of inflammatory re- pression profiling of nuclear hormone receptors in different T Tsponses in a large number of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis (1, 2). The Significance orphan nuclear receptor RORγt is the lineage-specific tran- scription factor that regulates the differentiation of Th17 cells Th17 cells are a subset of T cells that produce interleukin 17 (3). RORγt expression is induced specifically under Th17 dif- and other proinflammatory cytokines. They are involved in the ferentiation condition. Once expressed, RORγt in turn binds to development of autoimmune diseases such as multiple sclero- the loci of Th17 signature genes Il17a and Il17f and up-regulates sis and rheumatoid arthritis. Previous studies illustrated that γ their expression (4). Several small-molecule RORγt antagonists ROR t is a driver for Th17 cell differentiation. Here, we reveal α γ α γ were identified that can inhibit Th17 cell differentiation and REV-ERB as an antagonist of ROR t. REV-ERB and ROR t effector function (5–8). These findings suggested that RORγt share the same DNA binding motif. REV-ERB can inhibit the expression of RORγt target genes and suppress RORγt-driven inhibitors could be developed for treatment of autoimmune Th17 cell differentiation. Treatment with a synthetic REV-ERB diseases. However, RORγt is also known for its critical role in + + agonist delays the onset and impedes the progression of ex- promoting survival of CD4 CD8 double-positive (DP) thymo- perimental autoimmune encephalomyelitis (EAE), a mouse γ cytes. A recent study showed that ROR t inhibitor treatment model of multiple sclerosis. Taken together, our study suggests leads to not only reduced DP thymocyte numbers but also lim- that modulating REV-ERBα activity may be used to manipulate ited T cell repertoire diversity (9). Therefore, it is still a chal- Th17 cells in autoimmune diseases. lenge to develop a safe strategy to inhibit RORγt activity in Th17 cells in vivo. Author contributions: C.C., M.D., R.M.E., and Y.Z. designed research; C.C., C.-S.L., X.Z., Beyond their critical roles in Th17 cell differentiation, members L.A.S., Y.L., S.P.B., H.C., and T.M.K. performed research; C.C., C.-S.L., L.A.S., M.L., A.R.A., M.D., T.P.B., R.M.E., and Y.Z. analyzed data; and C.C., R.T.Y., M.D., and Y.Z. wrote of the ROR family are known to be key players in the circadian the paper. regulatory machinery, where they function as transcriptional ac- Reviewers: M.O.L., Memorial Sloan Kettering Cancer Center; and D.D.M., Baylor College tivators to turn on the expression of circadian genes (10, 11). In of Medicine. the circadian system, RORs’ transcriptional activity is opposed by The authors declare no conflict of interest. a pair of repressors, REV-ERBα and REV-ERBβ. Like RORs, This open access article is distributed under Creative Commons Attribution-NonCommercial- REV-ERBs are also members of the nuclear hormone receptor NoDerivatives License 4.0 (CC BY-NC-ND). family and play critical roles in circadian and metabolic regula- Data deposition: RNA-Seq data reported in this paper have been deposited in the Na- tions (12). REV-ERBs recognize the same RORE DNA sequence tional Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) data- base (accession no. PRJNA293472). ChIP-Seq data have been deposited in Gene Expression as RORs and function as transcriptional repressors to suppress the Omnibus (GEO), www.ncbi.nlm.nih.gov/geo (accession no. GSE72271). expression of ROR target genes (13, 14). Although the antagonistic 1To whom correspondence may be addressed. Email: [email protected] or [email protected]. relationship between ROR and REV-ERB was well established in This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. the circadian rhythm system, it is not clear if a similar interaction 1073/pnas.1907563116/-/DCSupplemental. exists in the T cell lineage. Published online August 27, 2019. 18528–18536 | PNAS | September 10, 2019 | vol. 116 | no. 37 www.pnas.org/cgi/doi/10.1073/pnas.1907563116 Downloaded by guest on October 1, 2021 REV-ERBα AB1.0 0.8 RORγt Tbet Foxp3 Gata3 Th1 0.8 Th17 5 0.8 4 0.6 iTreg 4 0.6 0.6 3 0.4 3 0.4 0.4 2 0.2 2 0.2 0.2 1 1 Relative expression 0.0 Day(s) 0.0 Day(s) 0 0.0 0 012 3 4 012 3 4 g 7 g re ve Th0 Th1Th2 iTre Th0 Th1Th2 Th0 Th1Th2 Naive Th17 Naive Th1 iT Nai Th17iTreg C Th1 Th17 Days RORγt REV-ERBα REV-ERBβ 12 34 1234 2.5 1.5 0.6 REV-ERBα Relative expression 2.0 1.0 0.4 REV-ERBβ 1.5 1.0 RORγ 0.5 0.2 0.5 Tbet 0.0 0.0 0.0 7 ve ve Th0 Th1 Th0 Th1Th2 Th0 Th1Th2 Th2Th17iTreg β-Actin Naive Th1 iTreg Nai Th17iTreg Nai 100 D hRORγt hTbet hREV-ERBα E IL-17A MIGR1 REV-ERBα REV-ERBβ 80 γ+ 15 60 3 *** 60 P=0.06 40 Donor 10 40 2 0 0 0 20 %IFN #1 Th1 0 5 20 **** 1 99.8 99.7 99.8 *** INFLAMMATION 50 IMMUNOLOGY AND 0 **** 0 0 40 20 60 8 * 30 *** 41.3 10.5 26.7 15 6 20 40 Relative expression ** Donor 10 4 Th17 10 % IL-17A+ 20 0 #2 5 2 α β 0 0 0 0.26 1.71 0.213 Th1 Th17 Th1 Th17 Th1 Th17 Control IFNγ REV-ERBREV-ERB #2 #1 FGl #2 #2 #1 #1 #2 #2 #2 #1 #2 #1 #1-ERBαREV β βREV BαREV BβREV ERB KEGG Pathway Term Count P value ERBα -ERB -ERBβREV -ERBα -ER - -ERBβ -ERBβ -ER Bα -ER - -ERBα #1 27 7.38E-07 T cell receptor signaling pathway MigR1 Control #1 MigR1 Control #2 REV REV REV REV REV REV REV MigR1 Control #2 MigR1 Control #1 MigR1 Contro MigR1 Control Jak-STAT signaling pathway 28 3.29E-05 Il-17a Pim1 Vav3 Il-17f Spry1 Ccl3 Chemokine signaling pathway 26 0.00334 Il-23r Stat2 Ncf1 5 0.01452 Tgfb3 Stat1 Ccr5 Circadian rhythm signaling Csf2 Il12rb Chemokine Cc14 27 Cytokine-cytokine receptor 0.05854 Ccl20 Il7r interaction Cysltr1 Stat5a Cd40 Ltb4r1 Stat3 Inhba Furin Irf9 Il9 Fam124b Jak2 Fas Vax2 Akt2 Il1r2 Th17 differentiation and function Pik3ca Kit Jak-Stat pathway Tnfsf11 Cry1 Akt3 interaction Arnt1 Myc Il15ra Cd27 Npas2 Il2ra Tnfsf8 Cytokine-cytokine receptor rhythm Bhlhe40 Socs2 Circadian Il2rb Il12rb2 Pik3cg Stat4 log2 fold change Fig. 1. REV-ERBα is up-regulated in Th17 cells and inhibits the expression of Th17 signature genes.
Recommended publications
  • GATA3 As an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: a Study with a Review of the Literature
    diagnostics Article GATA3 as an Adjunct Prognostic Factor in Breast Cancer Patients with Less Aggressive Disease: A Study with a Review of the Literature Patrizia Querzoli 1, Massimo Pedriali 1 , Rosa Rinaldi 2 , Paola Secchiero 3, Paolo Giorgi Rossi 4 and Elisabetta Kuhn 5,6,* 1 Section of Anatomic Pathology, Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44124 Ferrara, Italy; [email protected] (P.Q.); [email protected] (M.P.) 2 Section of Anatomic Pathology, ASST Mantova, Ospedale Carlo Poma, 46100 Mantova, Italy; [email protected] 3 Surgery and Experimental Medicine and Interdepartmental Center of Technology of Advanced Therapies (LTTA), Department of Morphology, University of Ferrara, 44121 Ferrara, Italy; [email protected] 4 Epidemiology Unit, Azienda Unità Sanitaria Locale-IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy; [email protected] 5 Division of Pathology, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, 20122 Milano, Italy 6 Department of Biomedical, Surgical, and Dental Sciences, University of Milan, 20122 Milano, Italy * Correspondence: [email protected]; Tel.: +39-02-5032-0564; Fax: +39-02-5503-2860 Abstract: Background: GATA binding protein 3 (GATA3) expression is positively correlated with Citation: Querzoli, P.; Pedriali, M.; estrogen receptor (ER) expression, but its prognostic value as an independent factor remains unclear. Rinaldi, R.; Secchiero, P.; Rossi, P.G.; Thus, we undertook the current study to evaluate the expression of GATA3 and its prognostic value Kuhn, E. GATA3 as an Adjunct in a large series of breast carcinomas (BCs) with long-term follow-up. Methods: A total of 702 Prognostic Factor in Breast Cancer consecutive primary invasive BCs resected between 1989 and 1993 in our institution were arranged Patients with Less Aggressive in tissue microarrays, immunostained for ER, progesterone receptor (PR), ki-67, HER2, p53, and Disease: A Study with a Review of GATA3, and scored.
    [Show full text]
  • A Core Transcriptional Network Composed of Pax2/8, Gata3 and Lim1 Regulates Key Players of Pro/Mesonephros Morphogenesis
    Developmental Biology 382 (2013) 555–566 Contents lists available at ScienceDirect Developmental Biology journal homepage: www.elsevier.com/locate/developmentalbiology Genomes and Developmental Control A core transcriptional network composed of Pax2/8, Gata3 and Lim1 regulates key players of pro/mesonephros morphogenesis Sami Kamel Boualia a, Yaned Gaitan a, Mathieu Tremblay a, Richa Sharma a, Julie Cardin b, Artur Kania b, Maxime Bouchard a,n a Goodman Cancer Research Centre and Department of Biochemistry, McGill University, 1160 Pine Ave. W., Montreal, Quebec, Canada H3A 1A3 b Institut de Recherches Cliniques de Montréal, Montréal, Québec, Canada H2W 1R7, Department of Anatomy and Cell Biology, Division of Experimental Medicine, McGill University, Montréal, Quebec, Canada, H3A 2B2 and Faculté de médecine, Université de Montréal, Montréal, Quebec, Canada, H3C 3J7. article info abstract Article history: Translating the developmental program encoded in the genome into cellular and morphogenetic Received 23 January 2013 functions requires the deployment of elaborate gene regulatory networks (GRNs). GRNs are especially Received in revised form crucial at the onset of organ development where a few regulatory signals establish the different 27 July 2013 programs required for tissue organization. In the renal system primordium (the pro/mesonephros), Accepted 30 July 2013 important regulators have been identified but their hierarchical and regulatory organization is still Available online 3 August 2013 elusive. Here, we have performed a detailed analysis of the GRN underlying mouse pro/mesonephros Keywords: development. We find that a core regulatory subcircuit composed of Pax2/8, Gata3 and Lim1 turns on a Kidney development deeper layer of transcriptional regulators while activating effector genes responsible for cell signaling Transcription and tissue organization.
    [Show full text]
  • UNIVERSITY of CALIFORNIA Los Angeles
    UNIVERSITY OF CALIFORNIA Los Angeles Circadian Gene Networks In Bone Regeneration A thesis submitted in partial satisfaction of the requirements for the degree Master of Science in Oral Biology by Nathaniel Raphael Hassan 2012 ABSTRACT OF THESIS Circadian Gene Networks In Bone Regeneration By Nathaniel Raphael Hassan Master of Science in Oral Biology University of California, Los Angeles, 2012 Professor Ichiro Nishimura, Chair BACKGROUND: Previous studies suggested that vitamin D played a significant role in bone regeneration, facilitating the establishment of implant osseointegration. A whole genome microarray study further suggested that the vitamin D axis might involve circadian rhythm gene expression in the bone peripheral tissue. OBJECTIVES: To identify key gene networks involved with vitamin D receptor in the bone regeneration process and to explore any correlation with circadian rhythm gene expression in bone marrow mesenchymal stromal/stem cells (BMSC). METHODS: The available whole gene microarray data was analyzed using the weighted gene correlation network analysis (WGCNA) R package and Cytoscape software. Any gene expression correlation was examined for vitamin D receptor (VDR) as well as circadian rhythm ii genes. Separately, Per 1 luciferase transgenic Wistar rats were then applied for in vitro evaluation on BMSC circadian rhythm. Per1::luc BMSCs were seeded on 35mm dishes and forskolin-synchronized luminescence was recorded across different media conditions. The recording media included growth medium containing F12 (10% Fetal Bovine Serum, 1% Pen- Strep and antibiotic) supplemented with or without 1 nM 1,25D. Luminescence was also recorded in F12 growth medium containing bone differentiation factors (beta glycerophosphate, Ascorbic acid and Dexamethasone) supplemented with 0, 1 or 10 nM 1,25D.
    [Show full text]
  • NPAS2 As a Transcriptional Regulator of Non-Rapid Eye Movement Sleep: Genotype and Sex Interactions
    NPAS2 as a transcriptional regulator of non-rapid eye movement sleep: Genotype and sex interactions Paul Franken*†‡, Carol A. Dudley§, Sandi Jo Estill§, Monique Barakat*, Ryan Thomason¶, Bruce F. O’Hara¶, and Steven L. McKnight‡§ §Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX 75390; *Department of Biological Sciences, Stanford University, Stanford, CA 94305; ¶Department of Biology, University of Kentucky, Lexington, KY 40506; and †Center for Integrative Genomics, University of Lausanne, CH-1015 Lausanne-Dorigny, Switzerland Contributed by Steven L. McKnight, March 13, 2006 Because the transcription factor neuronal Per-Arnt-Sim-type sig- delta frequency range is a sensitive marker of time spent awake (4, nal-sensor protein-domain protein 2 (NPAS2) acts both as a sensor 7) and local cortical activation (8) and is therefore widely used as and an effector of intracellular energy balance, and because sleep an index of NREMS need and intensity. is thought to correct an energy imbalance incurred during waking, The PAS-domain proteins, CLOCK, BMAL1, PERIOD-1 we examined NPAS2’s role in sleep homeostasis using npas2 (PER1), and PER2, play crucial roles in circadian rhythm gener- knockout (npas2؊/؊) mice. We found that, under conditions of ation (9). The NPAS2 paralog CLOCK, like NPAS2, can induce the increased sleep need, i.e., at the end of the active period or after transcription of per1, per2, cryptochrome-1 (cry1), and cry2. PER and sleep deprivation (SD), NPAS2 allows for sleep to occur at times CRY proteins, in turn, inhibit CLOCK- and NPAS2-induced when mice are normally awake. Lack of npas2 affected electroen- transcription, thereby closing a negative-feedback loop that is cephalogram activity of thalamocortical origin; during non-rapid thought to underlie circadian rhythm generation.
    [Show full text]
  • GATA3 Acts Upstream of FOXA1 in Mediating ESR1 Binding by Shaping Enhancer Accessibility
    Downloaded from genome.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press Research GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility Vasiliki Theodorou,1 Rory Stark,2 Suraj Menon,2 and Jason S. Carroll1,3,4 1Nuclear Receptor Transcription Lab, 2Bioinformatics Core, Cancer Research UK, Cambridge Research Institute, Li Ka Shing Centre, Cambridge CB2 0RE, United Kingdom; 3Department of Oncology, University of Cambridge, Cambridge CB2 OXZ, United Kingdom Estrogen receptor (ESR1) drives growth in the majority of human breast cancers by binding to regulatory elements and inducing transcription events that promote tumor growth. Differences in enhancer occupancy by ESR1 contribute to the diverse expression profiles and clinical outcome observed in breast cancer patients. GATA3 is an ESR1-cooperating transcription factor mutated in breast tumors; however, its genomic properties are not fully defined. In order to investigate the composition of enhancers involved in estrogen-induced transcription and the potential role of GATA3, we performed extensive ChIP-sequencing in unstimulated breast cancer cells and following estrogen treatment. We find that GATA3 is pivotal in mediating enhancer accessibility at regulatory regions involved in ESR1-mediated transcription. GATA3 silencing resulted in a global redistribution of cofactors and active histone marks prior to estrogen stimulation. These global genomic changes altered the ESR1-binding profile that subsequently occurred following estrogen, with events exhibiting both loss and gain in binding affinity, implying a GATA3-mediated redistribution of ESR1 binding. The GATA3-mediated redistributed ESR1 profile correlated with changes in gene expression, suggestive of its functionality. Chromatin loops at the TFF locus involving ESR1-bound enhancers occurred independently of ESR1 when GATA3 was silenced, indicating that GATA3, when present on the chromatin, may serve as a licensing factor for estrogen–ESR1-mediated interactions between cis-regulatory elements.
    [Show full text]
  • Neurobiological Functions of the Period Circadian Clock 2 Gene, Per2
    Review Biomol Ther 26(4), 358-367 (2018) Neurobiological Functions of the Period Circadian Clock 2 Gene, Per2 Mikyung Kim, June Bryan de la Peña, Jae Hoon Cheong and Hee Jin Kim* Department of Pharmacy, Uimyung Research Institute for Neuroscience, Sahmyook University, Seoul 01795, Republic of Korea Abstract Most organisms have adapted to a circadian rhythm that follows a roughly 24-hour cycle, which is modulated by both internal (clock-related genes) and external (environment) factors. In such organisms, the central nervous system (CNS) is influenced by the circadian rhythm of individual cells. Furthermore, the period circadian clock 2 (Per2) gene is an important component of the circadian clock, which modulates the circadian rhythm. Per2 is mainly expressed in the suprachiasmatic nucleus (SCN) of the hypothalamus as well as other brain areas, including the midbrain and forebrain. This indicates that Per2 may affect various neurobiological activities such as sleeping, depression, and addiction. In this review, we focus on the neurobiological functions of Per2, which could help to better understand its roles in the CNS. Key Words: Circadian rhythm, Per2 gene, Sleep, Depression, Addiction, Neurotransmitter INTRODUCTION and lives in organisms because it can impart effects from the level of cells to organs including the brain. Thus, it is neces- A circadian rhythm is any physiological process that displays sary to understand clock-related genes that are controlling the a roughly 24 hour cycle in living beings, such as mammals, circadian rhythm endogenously. plants, fungi and cyanobacteria (Albrecht, 2012). In organ- The Period2 (Per2) gene is a member of the Period family isms, most biological functions such as sleeping and feeding of genes consisting of Per1, Per2, and Per3, and is mainly patterns are adapted to the circadian rhythm.
    [Show full text]
  • A Combination of GATA3 and SOX10 Is Useful for the Diagnosis of Metastatic Triple-Negative Breast Cancer☆ Gary H
    Human Pathology (2019) 85,221–227 www.elsevier.com/locate/humpath Original contribution A combination of GATA3 and SOX10 is useful for the diagnosis of metastatic triple-negative breast cancer☆ Gary H. Tozbikian MD⁎, Debra L. Zynger MD Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA Received 9 July 2018; revised 2 November 2018; accepted 7 November 2018 Keywords: Summary In metastatic breast cancer (MBC), it can be difficult to establish the origin if the primary tumor is Triple negative; triple negative or if there is a loss of biomarker expression. SOX10 expression has been reported in primary Breast cancer; triple-negative breast cancer but is poorly studied in metastatic lesions. In this study, the diagnostic utility of SOX10; a panel of SOX10, GATA3, and androgen receptor (AR) in MBC negative for estrogen receptor, progester- GATA3; one receptor, and human epidermal growth factor receptor 2 was evaluated and compared with the expres- Metastatic; sion of these markers in the matched primary breast cancer. In a series of 57 triple-negative MBCs, 82% Primary were positive for GATA3, 58% for SOX10, and 25% for AR. Nearly all MBCs (95%) were positive for ei- ther GATA3 or SOX10, with 46% dual positive and 5% of cases negative for both markers. Most GATA3- negative MBC cases were SOX10 positive (70%). AR expression was only seen in GATA3-positive MBC (25%) and was significantly more frequent in SOX10-negative MBC (48%) versus SOX10-positive MBC (9%; P = .001). Concordance for GATA3, SOX10, and AR between the primary and metastasis was 89%, 88%, and 80%, respectively.
    [Show full text]
  • Circadian- and Sex-Dependent Increases in Intravenous Cocaine Self-Administration in Npas2 Mutant Mice
    bioRxiv preprint doi: https://doi.org/10.1101/788786; this version posted October 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Circadian- and sex-dependent increases in intravenous cocaine self-administration in Npas2 mutant mice Lauren M. DePoy1,2, Darius D. Becker-Krail1,2, Neha M. Shah1, Ryan W. Logan1,2,3, Colleen A. McClung1,2,3 1Department of Psychiatry, Translational Neuroscience Program, University of Pittsburgh School of Medicine 2Center for Neuroscience, University of Pittsburgh 3Center for Systems Neurogenetics of Addiction, The Jackson Laboratory Contact: Lauren DePoy, PhD 450 Technology Dr. Ste 223 Pittsburgh, PA 15219 412-624-5547 [email protected] Running Title: Increased self-administration in female Npas2 mutant mice Key words: circadian, sex-differences, cocaine, self-administration, addiction, Npas2 Abstract: 250 Body: 3996 Figures: 6 Tables: 1 Supplement: 3 Figures Acknowledgements: We Would like to thank Mariah Hildebrand and Laura Holesh for animal care and genotyping. We thank Drs. Steven McKnight and David Weaver for providing the Npas2 mutant mice. This work was funded by the National Institutes of Health: DA039865 (PI: Colleen McClung, PhD) and DA046117 (PI: Lauren DePoy). Disclosures: All authors have no financial disclosures or conflicts of interest to report. 1 bioRxiv preprint doi: https://doi.org/10.1101/788786; this version posted October 1, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Abstract Background: Addiction is associated With disruptions in circadian rhythms.
    [Show full text]
  • Correlation Between Circadian Gene Variants and Serum Levels of Sex Steroids and Insulin-Like Growth Factor-I
    3268 Correlation between Circadian Gene Variants and Serum Levels of Sex Steroids and Insulin-like Growth Factor-I Lisa W. Chu,1,2 Yong Zhu,3 Kai Yu,1 Tongzhang Zheng,3 Anand P. Chokkalingam,4 Frank Z. Stanczyk,5 Yu-Tang Gao,6 and Ann W. Hsing1 1Division of Cancer Epidemiology and Genetics and 2Cancer Prevention Fellowship Program, Office of Preventive Oncology, National Cancer Institute, NIH, Bethesda, Maryland; 3Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; 4Division of Epidemiology, School of Public Health, University of California at Berkeley, Berkeley, California; 5Department of Obstetrics and Gynecology, Keck School of Medicine, University of Southern California, Los Angeles, California; and 6Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China Abstract A variety of biological processes, including steroid the GG genotype. In addition, the PER1 variant was hormone secretion, have circadian rhythms, which are associated with higher serum levels of sex hormone- P influenced by nine known circadian genes. Previously, binding globulin levels ( trend = 0.03), decreasing we reported that certain variants in circadian genes 5A-androstane-3A,17B-diol glucuronide levels P P were associated with risk for prostate cancer. To pro- ( trend = 0.02), and decreasing IGFBP3 levels ( trend = vide some biological insight into these findings, we 0.05). Furthermore, the CSNK1E variant C allele was examined the relationship of five variants of circadian associated with higher
    [Show full text]
  • Integrative Bulk and Single-Cell Profiling of Premanufacture T-Cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-Cell Therapy
    Published OnlineFirst April 5, 2021; DOI: 10.1158/2159-8290.CD-20-1677 RESEARCH ARTICLE Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell Therapy Gregory M. Chen1, Changya Chen2,3, Rajat K. Das2, Peng Gao2, Chia-Hui Chen2, Shovik Bandyopadhyay4, Yang-Yang Ding2,5, Yasin Uzun2,3, Wenbao Yu2, Qin Zhu1, Regina M. Myers2, Stephan A. Grupp2,5, David M. Barrett2,5, and Kai Tan2,3,5 Downloaded from cancerdiscovery.aacrjournals.org on October 1, 2021. © 2021 American Association for Cancer Research. Published OnlineFirst April 5, 2021; DOI: 10.1158/2159-8290.CD-20-1677 ABSTRACT The adoptive transfer of chimeric antigen receptor (CAR) T cells represents a breakthrough in clinical oncology, yet both between- and within-patient differences in autologously derived T cells are a major contributor to therapy failure. To interrogate the molecular determinants of clinical CAR T-cell persistence, we extensively characterized the premanufacture T cells of 71 patients with B-cell malignancies on trial to receive anti-CD19 CAR T-cell therapy. We performed RNA-sequencing analysis on sorted T-cell subsets from all 71 patients, followed by paired Cellular Indexing of Transcriptomes and Epitopes (CITE) sequencing and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) on T cells from six of these patients. We found that chronic IFN signaling regulated by IRF7 was associated with poor CAR T-cell persistence across T-cell subsets, and that the TCF7 regulon not only associates with the favorable naïve T-cell state, but is maintained in effector T cells among patients with long-term CAR T-cell persistence.
    [Show full text]
  • Mapping Origins of Variation in Neural Trajectories of Human Pluripotent Stem Cells
    bioRxiv preprint doi: https://doi.org/10.1101/2021.03.17.435870; this version posted March 17, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Mapping origins of variation in neural trajectories of human pluripotent stem cells Suel-Kee Kim1,11,13, Seungmae Seo1,13, Genevieve Stein-O’Brien1,7,13, Amritha Jaishankar1,13, Kazuya Ogawa1, Nicola Micali1,11, Yanhong Wang1, Thomas M. Hyde1,3,5, Joel E. Kleinman1,3, Ty Voss9, Elana J. Fertig4, Joo-Heon Shin1, Roland Bürli10, Alan J. Cross10, Nicholas J. Brandon10, Daniel R. Weinberger1,3,5,6,7, Joshua G. Chenoweth1, Daniel J. Hoeppner1, Nenad Sestan11,12, Carlo Colantuoni1,3,6,8,*, Ronald D. McKay1,2,* 1Lieber Institute for Brain Development, 855 North Wolfe Street, Baltimore, MD 21205 2Department of Cell Biology, 3Department of Neurology, 4Departments of Oncology, Biomedical Engineering, and Applied Mathematics and Statistics, 5Department of Psychiatry, 6Department of Neuroscience, 7McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205 8Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD 21201 9Division of Preclinical Innovation, Nation Center for Advancing Translational Science / NIH, Bethesda, MD 20892 10Astra-Zeneca Neuroscience iMED., 141 Portland Street, Cambridge, MA 01239 11Department of Neuroscience, 12Departments of Genetics, of Psychiatry and of Comparative Medicine, Kavli Institute for Neuroscience, Program in Cellular Neuroscience, Neurodegeneration and Repair, Child Study Center, Yale School of Medicine, New Haven, CT 06510, USA. 13Co-first author *Corresponding authors: [email protected] (C.C.), [email protected] (R.D.M.) Lead contact: R.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]